Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Tolerance to Bronchoprotection in Mild Asthma
NCT05113615Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Tiotropium Bromide with Placebo (2 arms). Primary endpoint: Methacholine Provocative Dose 20. Started Dec 2021; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05113615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05113615.